A review on management of Udavarta Yonivyapad w. s. r. to primary Dysmenorrhea
Keywords:
Udavarta Yonivyapad, Primary Dysmenorrhea, Ayurveda, Apana Vata, Shamana, Shodhana, Vata VyadhiAbstract
Udavarta Yonivyapad described in Ayurvedic classics, is a gynaecological disorder characterized by the upward movement of Vata leading to pain, suppression of natural urges, and menstrual irregularities. It shows significant resemblance to Primary Dysmenorrhea, a common gynaecological condition in adolescent and young women, marked by painful menstruation without any underlying pelvic pathology. Despite modern pharmacological interventions, the recurrence and side effects of NSAID’s make the Ayurvedic approach highly relevant in offering a holistic and sustainable management strategy. This review aims to explore the pathophysiology, correlation, and comprehensive Ayurvedic management of Udavarta Yonivyapad in the context of Primary Dysmenorrhea, emphasizing classical and contemporary perspectives. Material Methods: A critical analysis of classical Ayurvedic texts such as Charaka Samhita, Sushruta Samhita, and Ashtanga Hridaya was undertaken to understand the Aetiology and treatment of Udavarta Yonivyapad. Modern literature was reviewed to understand the pathology and treatment options for Primary Dysmenorrhea. The comparative study enabled the correlation of both conditions and helped outline Ayurvedic management strategies including Shodhana (purificatory therapies), Shamana (palliative treatment), dietary regulations, lifestyle modifications, and the use of specific herbs like Hingu, Trivrutta Dashamool etc. Conclusion: The Ayurvedic approach provides a multifaceted management plan targeting the root cause vitiated Apana Vata. Therapies such as Abhyanga, Swedana, Basti, and internal medication with Vata-anulomana and Shoolaprashamana dravyas show promising results in reducing the severity and recurrence of dysmenorrhea symptoms. Additionally, lifestyle and dietary modifications play a pivotal role in long-term relief.
References
1. Korean J Fam Med 2022 Mar 17;43(2):101–108. doi: 10.4082/kjfm.21.0103 Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates (Rania Itani 1,*, Lama Soubra 2, Samar Karout 1, Deema Rahme 1, Lina Karout 3, Hani M J Khojah 4
2. M.B. Gebeyehu, A.B. Mekuria, Y.G. Tefera, D.A. Andarge, Y.B. Debay, G.S. Bejiga, et al.Prevalence, impact, and management practice of dysmenorrhea among university of Gondar students, Northwestern Ethiopia: a cross-sectional study
3. T.S. Midilli, E. Yasar, E. Baysal Dysmenorrhea characteristics of female students of health school and affecting factors and their knowledge and use of complementary and alternative medicine methods.
4. Tripathi R. Charak Samhita Part II, Chikitsa Sthana 30/8, Varanasi: Chaukhamba Surbharati Prakashana;2003:754
5. Atrideva Gupta. Astanga Samgraha. Sharira Sthana. Varanasi: Oriental Publishers; 2002:331.
6. Tripathi B. Ashtanga Hridayam Uttartantra 33/27, Varanasi: Chaukhamba Sanskrit Prakashan;2022: p.g. 1128.
7. Tiwari Premavati. Ayurvediya Prasuti tantra and Stree Roga, 2nd ed:Varnasi, 2005; pg 33.34
8. Dutta DC. Textbook of Gynaecology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2013. Chapter 13. Page No. 178.
9. Charak samhita of agnivesha vol.2 chikitsa sthana chapter 30, shlok 41,47,61. by Acharya Vidhyadhar Shukla and prof.Ravi Dutt Tripathi, choukhamba Sanskrit pratishthana Delhi, 2007; 757.
10. Charak samhita of agnivesha vol.2 chikitsa sthana chapter 30, shlok 110,111. by Acharya Vidhyadhar Shukla and prof.Ravi Dutt Tripathi, choukhamba Sanskrit pratishthana Delhi, 2007; 757
11. Tiwari Premavati. Ayurvediya Prasuti tantra and Stree Roga, 2nd ed:Varnasi, 2005; pg 87
12. Burnett M, Lemyre M. No. 345: primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2017;39:585–95. doi: 10.1016/j.jogc.2016.12.023. [DOI] [PubMed] [Google Scholar]
13. ACOG committee opinion no. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132:e249–58. doi: 10.1097/AOG.0000000000002978. [DOI] [PubMed] [Google Scholar]
14. Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020;323:268–9. doi: 10.1001/jama.2019.16921. [DOI] [PubMed] [Google Scholar]
15. Abreu-Sanchez A, Parra-Fernandez ML, Onieva-Zafra MD, Ramos-Pichardo JD, Fernandez-Martinez E. Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in southern Spain. Healthcare (Basel) 2020;8:302. doi: 10.3390/healthcare8030302. [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Mendiratta V, Lentz GM. In: Comprehensive gynecology. 7th ed. Lobo RA, Gershenson DM, Lentz GM, editors. Philadelphia (PA): Elsevier Inc; 2017. Primary and secondary dysmenorrhea, premenstrual syndrome, and premenstrual dysphoric disorder; pp. 815–28. [Google Scholar]
17. Oladosu FA, Tu FF, Hellman KM. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018;218:390–400. doi: 10.1016/j.ajog.2017.08.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opin Pharmacother. 2012;13:2157–70. doi: 10.1517/14656566.2012.725045. [DOI] [PubMed] [Google Scholar]
19. Ryan SA. The treatment of dysmenorrhea. Pediatr Clin North Am. 2017;64:331–42. doi: 10.1016/j.pcl.2016.11.004. [DOI] [PubMed] [Google Scholar]
20. Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005;27:1117–46. doi: 10.1016/s1701-2163(16)30395-4. [DOI] [PubMed] [Google Scholar]
21. ACOG committee opinion no. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132:e249–58. doi: 10.1097/AOG.0000000000002978. [DOI] [PubMed] [Google Scholar]
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Ayurline: International Journal of Research in Indian Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
I Â declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.
